Imatinib
S0033 (one of the dose trials)
Novartis · Phase 3 · Terminated · Enrollment 748
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Imatinib
Novartis · Phase 3 · Terminated · Enrollment 748
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.